ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc (EGRX)

2,14
0,00
(0,00%)
Geschlossen 16 Februar 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Professionelle Tools für Privatanleger.

Wichtige Statistiken und Details

Current Price
2,14
Gebot
2,27
Fragen
2,30
Volumen
-
0,00 Tagesbereich 0,00
1,80 52-Wochen-Bereich 6,81
Marktkapitalisierung
Handelsende
2,14
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
12.986.971
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,78
Gewinn pro Aktie (EPS)
2,74
Erlöse
316,61M
Nettogewinn
35,64M

Über Eagle Pharmaceuticals Inc

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The compan... Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
Eagle Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EGRX. The last closing price for Eagle Pharmaceuticals was US$2,14. Over the last year, Eagle Pharmaceuticals shares have traded in a share price range of US$ 1,80 to US$ 6,81.

Eagle Pharmaceuticals currently has 12.986.971 shares in issue. The market capitalisation of Eagle Pharmaceuticals is US$27,79 million. Eagle Pharmaceuticals has a price to earnings ratio (PE ratio) of 0.78.

EGRX Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1002.142.142.1400CS
4002.142.142.1400CS
12002.142.142.1400CS
26-1.87-46.63341645894.015.451.8616662.98316405CS
52-3.25-60.29684601115.396.811.81006054.33133538CS
156-46.47-95.597613659748.6153.781.814811920.29522709CS
260-51.54-96.013412816753.6858.251.814329630.21355168CS

EGRX - Frequently Asked Questions (FAQ)

What is the current Eagle Pharmaceuticals share price?
The current share price of Eagle Pharmaceuticals is US$ 2,14
How many Eagle Pharmaceuticals shares are in issue?
Eagle Pharmaceuticals has 12.986.971 shares in issue
What is the market cap of Eagle Pharmaceuticals?
The market capitalisation of Eagle Pharmaceuticals is USD 27,79M
What is the 1 year trading range for Eagle Pharmaceuticals share price?
Eagle Pharmaceuticals has traded in the range of US$ 1,80 to US$ 6,81 during the past year
What is the PE ratio of Eagle Pharmaceuticals?
The price to earnings ratio of Eagle Pharmaceuticals is 0,78
What is the cash to sales ratio of Eagle Pharmaceuticals?
The cash to sales ratio of Eagle Pharmaceuticals is 0,09
What is the reporting currency for Eagle Pharmaceuticals?
Eagle Pharmaceuticals reports financial results in USD
What is the latest annual turnover for Eagle Pharmaceuticals?
The latest annual turnover of Eagle Pharmaceuticals is USD 316,61M
What is the latest annual profit for Eagle Pharmaceuticals?
The latest annual profit of Eagle Pharmaceuticals is USD 35,64M
What is the registered address of Eagle Pharmaceuticals?
The registered address for Eagle Pharmaceuticals is CORPORATION TRUST CENTER, 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Eagle Pharmaceuticals website address?
The website address for Eagle Pharmaceuticals is www.eagleus.com
Which industry sector does Eagle Pharmaceuticals operate in?
Eagle Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
JTAIJet AI Inc
US$ 6,02
(133,33%)
101,64M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
248,48M
WRDWeRide Inc
US$ 31,4877
(83,39%)
20,57M
INLFINLIF Limited
US$ 16,27
(80,58%)
7,67M
MBRXMoleculin Biotech Inc
US$ 2,1201
(66,94%)
134,88M
BLACBellevue Life Sciences Acquisition Corporation
US$ 3,08
(-56,31%)
430,77k
BLACUBellevue Life Sciences Acquisition Corporation
US$ 3,36
(-52,68%)
5,21k
CSAICloudastructure Inc
US$ 19,0001
(-49,58%)
1,03M
NEXNNexxen International Ltd
US$ 10,30
(-49,16%)
164,82k
BSLKBolt Projects Holdings Inc
US$ 0,6626
(-46,13%)
13,4M
CNSPCNS Pharmaceuticals Inc
US$ 0,1415
(31,26%)
489,28M
MGOLMGO Global Inc
US$ 0,7176
(-15,08%)
417,31M
SRMSRM Entertainment Inc
US$ 0,6999
(95,50%)
254,39M
INTCIntel Corporation
US$ 23,60
(-2,20%)
230,26M
NVDANVIDIA Corporation
US$ 138,85
(2,63%)
194,99M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock